TERT and neoplasm: Importantly, the present data was able to show the effect of TERT mutation C228T on the 5-year disease-free survival, which was 20.0% for patients harboring this mutation vs. 63.0% for patients without this mutation, being therefore associated with an increased risk of tumor relapse.